Raed M. Al-Rajabi, MD

Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.

Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.

Better defining which patients with GI cancers are preferred candidates for adoptive cellular therapies may help optimize outcomes.